Skip to main content
spacbrain

Roivant Sciences Ltd.

CIK 0001635088

1 SPAC with a current declared position, filed between Oct 4, 2023 and Oct 4, 2023. 0 of them were re-affirmed in the last 12 months. The rest are the filer’s last word on a position, not proof it is still held: an amendment is only required on a material change, so a fund that sells below 5% may never file again.

This filer has not filed a Schedule 13 on any SPAC since Oct 4, 2023. Read the page below as a record of what was declared, not as a register of what is held.

SPACs declared
1
every position whose latest statement stands — the record
Re-affirmed in 12 months
0
filed inside 365 days — what a reader means by "owns"
Still live
0
positions in SPACs still searching or in an announced deal
Median stake
55.3%
no percentage stated on the cover pages
1 activist (13D)7 superseded statements on file

Positions

one row per SPAC — every figure read from the accession in the Source column
1 of 1 shown · 1 position has not been amended in over a year
SPACVotingDispositiveSource
IMVTHealth Sciences Acquisitions Corp55.3%79,815,33179,815,331 / 079,815,331 / 0Closed (deSPAC)Oct 4, 2023StaleSC 13D/A · may seek to influence control0001140361-23-046991 opens on sec.gov in a new tab7 earlier statements
7 superseded statements

An amendment replaces a stake as current; it never erases the record of it. These are the earlier statements, each with the accession that replaced it — kept because “what did this filer say in 2022” is a different question from “what does it say now”, and only the second one has an answer above.

  • IMVT Health Sciences Acquisitions Corp63.8% · SC 13D/A Aug 2, 2021replaced Oct 4, 2023 by 0001140361-23-046991
  • IMVT Health Sciences Acquisitions Corp57.5% · SC 13D/A Mar 8, 2021replaced Aug 2, 2021 by 0001104659-21-098576
  • IMVT Health Sciences Acquisitions Corp57.6% · SC 13D/A Sep 18, 2020replaced Mar 8, 2021 by 0001104659-21-032967
  • IMVT Health Sciences Acquisitions Corp54.2% · SC 13D/A Sep 4, 2020replaced Sep 18, 2020 by 0001104659-20-106544
  • IMVT Health Sciences Acquisitions Corp62.1% · SC 13D/A May 15, 2020replaced Sep 4, 2020 by 0001104659-20-102700
  • IMVT Health Sciences Acquisitions Corp58.2% · SC 13D/A Apr 17, 2020replaced May 15, 2020 by 0001104659-20-061794
  • IMVT Health Sciences Acquisitions Corp66.3% · SC 13D Dec 20, 2019replaced Apr 17, 2020 by 0001104659-20-048300

Appears alongside

other filers with a current declared position in the same SPACs

Co-occurrence in the disclosure record, and nothing more. It is not evidence of a group, an agreement or acting in concert — filers who act as a group say so on the cover page and file a 13D. Two arbitrage funds above 5% in the same shell is the ordinary shape of this market. The second number restricts both sides to statements filed in the last 12 months, because a 2021 stake beside a 2026 one is two facts about two different years.

Every percentage above is the one printed on the cover page of the filing cited beside it — a percentage of the shares outstanding on that date. A SPAC’s float collapses at each redemption, so two of these percentages are percentages of two different companies and they do not add. Rows are one per SPAC: where a joint schedule names several reporting persons, the largest single figure is shown rather than their sum, because a manager and the funds it advises beneficially own the same shares. Nothing on this page is derived from a 13F, a vendor holdings file or a press release. See how this is built.